FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/06/054031 [Registered on: 16/06/2023] Trial Registered Prospectively
Last Modified On: 22/08/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Medical Device 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison of the Efficacy of 3 modalities for the treatment of Striae Distensae or Stretchmarks - Fractional Carbon Dioxide Laser versus Autologous Platelet Rich Plasma versus Microneedling with topical Aloe Vera Gel.  
Scientific Title of Study   Efficacy of Fractional Carbon Dioxide Laser versus Autologous Platelet Rich Plasma versus Microneedling with topical Aloe Vera Gel in the Treatment of Striae Distensae 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. Sumedha Tirthani 
Designation  Junior resident  
Affiliation  R L Jalappa Hospital  
Address  Room no. 26, Department of Dermatology, RL Jalappa Hospital, Sri Devaraj Urs Medical College, Tamaka, Kolar

Kolar
KARNATAKA
563101
India 
Phone  8989430500  
Fax    
Email  sumedhatirthani@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Rajashekar TS 
Designation  Professor and Head of Department, Department of Dermatology, Sri Devaraj Urs Medical College  
Affiliation  R L Jalappa Hospital  
Address  Room no 26, Department of Dermatology, Sri Devaraj Urs Medical College Kolar

Kolar
KARNATAKA
563101
India 
Phone  9448316136  
Fax    
Email  yeshitss1@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr. Sumedha Tirthani 
Designation  Junior resident  
Affiliation  R L Jalappa Hospital 
Address  Room no 26, Department of Dermatology, RL Jalappa Hospital, Sri Devaraj Urs Medical College Kolar

Kolar
KARNATAKA
563101
India 
Phone  8989430500  
Fax    
Email  sumedhatirthani@gmail.com  
 
Source of Monetary or Material Support  
RL Jalappa Hospital, Sri Devaraj Urs Medical College, Tamaka, Kolar 
 
Primary Sponsor  
Name  Dr Sumedha Tirthani 
Address  Department of Dermatology, Sri Devaraj Urs Medical College, Kolar, Karnataka 563101 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sumedha Tirthani  RL Jalappa Hospital, Sri Devaraj Urs Medical College   Room no 26, Department of Dermatology, RL Jalappa Hospital, Sri Devaraj Urs Medical College
Kolar
KARNATAKA 
8989430500

sumedhatirthani@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Sri Devaraj Urs Medical College Institutional ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: R234||Changes in skin texture,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Fractional Carbon Dioxide Laser  For 6 sittings at 3 week intervals 
Intervention  MICRONEEDLING WITH TOPICAL ALOE VERA GEL  For 6 sittings at 3 week intervals 
Comparator Agent  NIL  NIL 
Intervention  Platelet Rich Plasma   For 6 sittings at 3 week intervals 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1. Patients of both genders with striae Distensae of all grades over any site on the body
2. Patients who have not taken treatment for striae distensae either topppical or systemic in the past 6 months 
 
ExclusionCriteria 
Details  1.Patients on systemic isotretinoin or corticosteroids.
2.Patients with history of keloid formation.
3.Patients with any connective tissue disease.
4.Patients with disease affecting the wound-healing process.
5.Patients with other systemic illness – cardiac, renal, hepatic illness.
6.Severely Immunocompromised
7.Pregnancy, Lactation
8.Patients who have cold intolerance
9.Patients taking photosensitive drugs and photosensitivity
10.Patient not willing for study 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1. Measurement of efficacy of modalities on the basis of quartile grading score.
2. % reduction in width of Striae
3. Patient satisfaction using Likert Satisfaction scale 
1. before each setting - every 3 weeks
2, 3 - at end of 6 settings and 3 weeks after the last setting - at 15 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Post procedural adverse effects & healing effects of Fractional Carbon Dioxide Laser, PRP, and Microneedling with topical aloe vera gel in treatment of striae distensae.  1. before each setting - every 3 weeks, at end of 6 settings  
 
Target Sample Size   Total Sample Size="108"
Sample Size from India="108" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   25/06/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="5"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   None Yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is to Determine the efficacy of Fractional CO2 Laser versus PRP versus Microneedling with Aloe Vera Gel in the treatment of Striae Distensae. As of now, no study has been done to compare these three groups. Thus making this study a first of its kind. 
Close